Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND

AIMS: To assess the effect of sodium‐glucose cotransporter‐2 inhibitor dapagliflozin on natriuresis, blood pressure (BP) and volume status in patients with chronic kidney disease (CKD) without diabetes. MATERIALS AND METHODS: We performed a mechanistic open‐label study (DAPASALT) to evaluate the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Taha, Scholtes, Rosalie, Greasley, Peter J., Cherney, David Z. I., Dekkers, Claire C. J., Vervloet, Marc, Danser, Alexander H. J., Barbour, Sean J., Karlsson, Cecilia, Hammarstedt, Ann, Li, Qiang, Laverman, Gozewijn D., Bjornstad, Petter, van Raalte, Daniel H., Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262818/
https://www.ncbi.nlm.nih.gov/pubmed/35478433
http://dx.doi.org/10.1111/dom.14729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262818/
https://www.ncbi.nlm.nih.gov/pubmed/35478433
http://dx.doi.org/10.1111/dom.14729

Ejemplares similares